Events at this location

Recent Posts

• DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit
• DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience
• DiaCarta to Become a Publicly Listed Company Through Merger with HH&L Acquisition Co.
• Dealing with the Respiratory Viruses that Cause Covid-19 or Flu
• DiaCarta Receives CE-IVD Mark for Its SARS-CoV-2 Flu A/B Combo Test